FR940525-2-00067 FR940525-2-00055 Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993_International Pharmaceutical Aerosol Consortium for Toxicology Testing of HFA&hyph;227 Notice is hereby given that, on April 20, 1994, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (``the Act''), the International Pharmaceutical Aerosol Consortium for Toxicology Testing of HFA&hyph;227 (``IPACT&hyph;II'') filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing a change in its membership status. The notifications were filed for the purpose of extending the Act's provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, IPACT&hyph;II reinstated Schering-Plough Corporation, Madison, NJ as a member. Schering previously had terminated its membership in IPACT&hyph;II (58 FR 25657). No other changes have been made in the membership, activities, or planned activity of IPACT&hyph;II. On February 21, 1991, IPACT&hyph;II filed its original notification pursuant to Section 6(b) of the Act. The Department of Justice published a notice in the Federal Register pursuant to section 6(b) of the Act on April 2, 1991 (56 FR 13489). The last notification was filed with the Department on January 14, 1993. A notice was published in the Federal Register pursuant to section 6(b) of the Act on April 27, 1993 (58 FR 2567). Constance K. Robinson, Director of Operations Antitrust Division. [FR Doc. 94&hyph;12754 Filed 5&hyph;24&hyph;94; 8:45 am] BILLING CODE 4410&hyph;01&hyph;M
